маг. фарм. Деян Йорданов Йосифов, докторант

Медицински Университет София
Фармацевтичен факултет
Лаборатория по експериментална химиотерапия и молекулярна фармакология

София 1000, ул. „Дунав” №2
тел: (02) 9236559

email: deyanyosifov@cetrh.org

• New York Academy of Sciences

1. M. Zaharieva, N. Petkov, B. Pilicheva, D. Yosifov, G. Momekov, S. Konstantinov and M. Berger (2005) Evaluation of the combined effects of erucylphospho-N,N,N-trimethylpropylammonium (ErPC3), Gleevec and Bendamustine on normal and malignantly transformed haemopoietic cells. Pharmacia LII (1-2), 90-98
2. D. Yosifov, I. Dineva, M. Zaharieva, S. Konstantinov, M. Berger (2007) The Expression Level of the Tumor Suppressor Retinoblastoma Protein (Rb) Influences the Antileukemic Efficacy of Erucylphospho-N,N,N-Trimethylpropylammonium (ErPC3). Cancer Biology and Therapy 6 (6), 930-935
3. D. Yosifov, S. Konstantinov, M. Berger (2009) Erucylphospho-N,N,N-trimethylpropylammonium (Erufosine) Shows Substantial Cytotoxicity in Multiple Myeloma Cells. Annals of the New York Academy of Sciences 1171, 350-358